Sotagliflozin Linked to Improved Glycemic Control in T1DM
Primary end point achieved by more patients with type 1 diabetes receiving any insulin therapy
Exenatide Doesn’t Up Cardiovascular Risk in T2DM
Exenatide found to be non-inferior to placebo with respect to safety for patients with type 2 diabetes
American Society for Bone and Mineral Research, Sept. 8-11
The American Society for Bone and Mineral Research Annual Meeting The annual meeting of the American Society for Bone and Mineral Research was...
Some Aspects of Empathy Improve During Medical Training
Decrease in empathy as assessed by JSPE, but overall cognitive empathy improved on the QCAE
Intestinal Glucose Stimulation Has Anti-Incretin Effect
Insulin sensitivity lower during oral versus IV glucose administration; difference amplified in obese
Vitamin D Deficiency Tied to Neuropathic Pain
Findings among patients diagnosed with rheumatoid arthritis
Sedentary Time Volume, Accrual Linked to All-Cause Mortality
Greatest risk of death for participants classified as high for sedentary time volume and bout duration
2017 Standards of Medical Care in Diabetes Released
Recommendations for T1D focus on monitoring, pharmacologic approaches to glycemic management
Are Physicians Obligated to Help on Planes?
One administrative physician explains his sense of obligation to help
Biomarkers Can Predict Rapid Drop in Renal Function in T2DM
ApoA4, CD5L, C1QB, IBP3 may improve prediction of rapid decline in renal function in type 2 diabetes